DiaMedica Therapeutics (DMAC) stock: insider trades, news & valuation
Net buyingShare price and insider trades
DiaMedica Therapeutics insider trading at a glance (Oct 9, 2026): in the past 12 months, 1 insider bought $7.6M and 0 sold $0 of DMAC stock on the open market.
Get emailed when insiders cluster-buy stocks like DMAC
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
DMAC insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | — | 0 |
| Q2 2026 | — | 0 | — | 0 |
| Q1 2026 | — | 0 | — | 0 |
| Q4 2025 | $7.6M | 7 | — | 0 |
Valuation, profit and volume
Summary
Over the past 12 months, 1 DiaMedica Therapeutics Inc. insider reported open-market purchases totaling $7.6M, while 0 insiders reported sales totaling $0.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Dec 8SEC | Ab Trill10% Owner | Buy | 240,3528,375,092 held (+3%) | $7.21 | $1.7M | +15.5% | — |
| Dec 8SEC | Ab Trill10% Owner | Buy | 208,8728,712,390 held (+2%) | $7.41 | $1.5M | +12.4% | — |
| Dec 8SEC | Ab Trill10% Owner | Buy | 182,8828,134,740 held (+2%) | $6.75 | $1.2M | +23.4% | — |
| Dec 8SEC | Ab Trill10% Owner | Buy | 187,3937,951,858 held (+2%) | $6.52 | $1.2M | +27.8% | — |
| Dec 8SEC | Ab Trill10% Owner | Buy | 128,4268,503,518 held (+2%) | $7.41 | $952K | +12.4% | — |
| Dec 8SEC | Ab Trill10% Owner | Buy | 73,0998,825,742 held (+1%) | $8.57 | $626K | -2.8% | — |
| Dec 8SEC | Ab Trill10% Owner | Buy | 40,2538,752,643 held (+0%) | $7.89 | $318K | +5.6% | — |
Insiders at DiaMedica Therapeutics Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Ab Trill10% Owner | $7.6M | — | Dec 8, 2025 | — |
DMAC stock: common questions
Are DiaMedica Therapeutics Inc. insiders buying DMAC stock?
In the past 12 months, 1 insiders reported open-market purchases of DMAC worth $7.6M. The latest was 10% Owner Ab Trill bought $1.7M of DMAC at $7.21 — largest purchase by this insider in our records.
Are DiaMedica Therapeutics Inc. insiders selling DMAC stock?
0 insiders reported sales worth $0 over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is DMAC's 52-week range?
Over the past year DMAC has traded between $5.33 and $9.39. It last closed at $8.33 on Oct 9, 2026.